Vaccines and disease-modifying treatments

Emmanuelle Waubant, Gavin Giovannoni, Chris Hawkes, Michael Levy

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish (US)
Pages (from-to)A1-A2
JournalMultiple Sclerosis and Related Disorders
Volume26
DOIs
StatePublished - Nov 2018

Keywords

  • Alemtuzumab
  • B cell depleting agents
  • Disease-modifying therapies
  • Multiple sclerosis
  • Neuromyelitis optica spectrum disorder
  • Ocrelizumab
  • Vaccines

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this